Notably, one analysis of the FDA Adverse Event Reporting System (FAERS) looked at reports of sexual dysfunction (including ED, decreased libido, and orgasmic disorders) in men on GLP-1 RAs
It has been found in certain diseases that those afflicted have deficiencies of Glutathione and once treated with supplemental glutathione, see much improvement in how they handle symptoms of their condition
Monitoring at 6 to 8 Weeks Recheck ALT, AST, fasting glucose, and IGF-1 six to eight weeks after starting therapy
It is not intended for human consumption, medical diagnosis, treatment, or prevention of any disease
Discontinue GLP-1 if suspected and promptly seek medical advice.